Data as of Sep 13, 2026. Both funds on the fields they both publish, from the same sources.
VIG vs XLV: how they differ
VIG and XLV hold 0% of their weight in the same names, and XLV returned more over the year.
Vanguard Dividend Appreciation Index Fund and State Street(R) Health Care Select Sector SPDR(R) ETF.
What they hold in common
By the books each fund has filed, VIG and XLV hold 0% of their money in the same securities at the same weight.
| Only in VIG | Only in XLV |
|---|---|
| Broadcom Inc 5.21% | ELI LILLY + CO 14.87% |
| Apple Inc 4.10% | JOHNSON + JOHNSON 10.73% |
| Microsoft Corp 3.99% | ABBVIE INC 7.54% |
| JPMorgan Chase & Co 3.61% | MERCK + CO. INC. 5.98% |
| Eli Lilly & Co 3.36% | UNITEDHEALTH GROUP INC 5.90% |
| Exxon Mobil Corp 2.92% | THERMO FISHER SCIENTIFIC INC 3.75% |
| Walmart Inc 2.62% | AMGEN INC 3.46% |
| Johnson & Johnson 2.51% | ABBOTT LABORATORIES 3.01% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Apr 30, 2026 and Sep 10, 2026.
| VIG Vanguard Dividend Appreciation Index Fund | XLV State Street(R) Health Care Select Sector SPDR(R) ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | Vanguard | State Street |
| What it is | Dividend growth | Health care |
| Total return, 1 year | +12.4% | +20.4% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | −5.1 pts | +2.9 pts |
| Expense ratio | 0.04% | 0.08% |
| Already in the S&P 500 | 95.7% | 100.0% |
| Holdings | 332 | 63 |
VIG in plain words
VIG is an index equity fund tracking the Dividend growth. Over the year to Sep 11, 2026 it returned +12.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.04% a year. By its holdings filed for Apr 30, 2026, 96% of the fund by weight is stocks the S&P 500 also holds, across 332 positions, with the top ten at 32.7%.
XLV in plain words
XLV is an index equity fund tracking the Health care. Over the year to Sep 11, 2026 it returned +20.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.08% a year. By its holdings filed for Sep 10, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 63 positions, with the top ten at 60.9%. It sat 5.9% below its high of Aug 19, 2026 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, VIG or XLV?
- In the year to Sep 13, 2026, with distributions reinvested, VIG returned +12.4% and XLV returned +20.4%, so XLV returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, VIG or XLV?
- VIG charges 0.04% a year and XLV charges 0.08%, so VIG is cheaper. Fees come from each fund's prospectus.
- How much do VIG and XLV overlap with the S&P 500?
- By their latest filed holdings, 96% of VIG and 100% of XLV by weight is stocks the S&P 500 already holds. Between the two funds, 0% of their books are the same securities at the same weight.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, VIG against XLV, data as of Sep 13, 2026. https://etfiq.com/compare/any/vig-vs-xlv Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources